Navigation Links
Health Robotics Releases Results of First 20 i.v.STATION's Return On Investment (ROI) Studies in the USA and Canada
Date:9/8/2010

sterile doses to compounded IVs manufactured by 6 Pharmacy Outsourcing and Pre-Mix/Frozen solutions companies. Health Robotics' web-registered authorized users may access i.v.STATION's ROI case studies and custom Microsoft Excel tools at http://www.health-robotics.com/en/solutions/i-v-station/

"i.v.STATION's $300,000 price, combined with its plug-and-play installation, flexibility of IV Bags/Vials/Syringes, ISO-5 controlled environment, and unprecedented robotic throughput, has already revolutionized Non-Hazardous Sterile Compounding in North America. Multiple hospital studies have proven an i.v.STATION's 3-to-1 cost advantage over Pre-Mix/Frozen solutions by Baxter, B. Braun, and Hospira, resulting on an average 8-month payback period to American hospitals utilizing between 1,200 and 1,400 median Minibag Plus, Duplex, or ADD-Vantage IV doses per month. As many North American hospitals have lately been forced towards increased IV Outsourcing as a result of recent IV drug shortages, i.v.STATION arrives at the right place and at the right time, offering a much more cost effective solution to the widespread scarcity problem in selected antibiotics, pain therapy, and other IV drug classes, while providing Health-System Pharmacies with much more control over Batch IV production and reduced IV waste," stated Gaspar DeViedma, Health Robotics' Executive Vice President.

i.v.STATION represents a revolutionary approach in the quest for safe, accurate, efficient, cost effective, and ready-to-administer intravenous patient doses. i.v.STATION offers unprecedented reduction of IV medication errors, USP 797 compliance, compatibility with 75+ different Syringe and IV Bags brands/sizes, reduction of IV waste, and significant labor savings: all within a scalable, cost-effective, distributed, and fail-safe architecture.

"i.v.STATION has also consistently revealed a 6-to-1 cost advantage over
'/>"/>

SOURCE Health Robotics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
2. SCAN Health Plan Offers Seniors Five Tips to Prepare for Surgery
3. Mergent, Inc. Announces Changes to the HealthShares(TM) European Drugs Index
4. Concentric Medical(R) Announces Co-Marketing Agreement With InTouch Health(R) to Advance Acute Ischemic Stroke Care
5. Mindray Medical to Attend Morgan Stanley Global Healthcare Unplugged Conference
6. BioNeutrals Ygiene(TM) New Hospital Grade Disinfectant Will Save Lives and Billions of Dollars Annually at Health Care Facilities Around the World
7. RF Technologies(R) Installs Safe Place(R) Solution for Pediatric and Infant Security at ProHealth Cares Waukesha Memorial Hospital
8. Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV
9. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
10. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
11. Beckman Coulter to Present at the Thomas Weisel Healthcare Conference 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... Baltimore, MD (PRWEB) November 24, 2014 ... recruiting underrepresented patient populations into clinical trials at ... Maryland. , “Continental was created with the ... trials play a fundamental role in medical advances," ... the Tuskegee syphilis experiment to the immortal cell ...
(Date:11/23/2014)... 23, 2014 Apiscent Labs, a ... fine chemical ingredients to the global pharmaceutical and ... its new website, Apiscent.com. , The Apiscent.com homepage ... clean design, easy navigation, rotating images and content ... stand out. , The company’s work ...
(Date:11/22/2014)... RURO, Inc., a leading LIMS, RFID ... version 5.1.4. , RURO’s deployment teams have been ... in RURO’s 8 year history. Many deployments have ... version 5.1.4 is the perfect example – the ... , Limfinity® 5.1.4 release highlights – more than ...
(Date:11/22/2014)... --   , ... KLOX    Mariano Rodriguez ... bestellt    KLOX ist bestens vorbereitet, ... Behandlungssystems zur Wundheilung zu beginnen    , ... erfreut, die folgenden personellen Veränderungen anzukündigen: ...
Breaking Biology Technology:At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 2At Continental Clinical Solutions, CEO Saleh Stevens Focuses on Diversity in Clinical Trial Recruitment at Maryland Site 3RURO Announces Limfinity® version 5.1.4 2KLOX Technologies meldet Neubesetzung von Führungspositionen 2KLOX Technologies meldet Neubesetzung von Führungspositionen 3KLOX Technologies meldet Neubesetzung von Führungspositionen 4KLOX Technologies meldet Neubesetzung von Führungspositionen 5
... Inc. (OTC: SCLR) today announced that it has closed ... 8% Senior Secured Convertible Debentures due 2013 (the "Debentures") ... up to $1.75 million principal amount of Debentures.  The ... maximum of $1.75 million, until June 30, 2011, unless ...
... Background : The U.S. House ... House agricultural appropriations bill, co-sponsored by Rep. Don Young (R-AK) ... Food and Drug Administration approval of salmon grown from AquaBounty ... fewer than ten of the total 435 House members. ...
... 16, 2011 Chiltern International Limited (Chiltern), a ... financial investment in Endpoint Clinical, Inc. (endpoint) further ... in April 2009. Glenn ... increase our investment in endpoint reflects our aligned ...
Cached Biology Technology:SCOLR Pharma, Inc. Announces Initial Closing of Private Placement 2SCOLR Pharma, Inc. Announces Initial Closing of Private Placement 3Statement by Ronald L. Stotish, Ph.D., President and CEO of AquaBounty Technologies 2Chiltern Announces Additional Investment in Endpoint 2
(Date:11/18/2014)... , Nov. 17, 2014 The Parenteral Drug ... U.S. regulatory agencies will speak and at least seven more ... Conference at the Omni Shoreham Hotel in Washington ... once again to have significant support from the regulatory agencies ... Europe in our effort to help advance ...
(Date:11/10/2014)... detergent pods began appearing on U.S. store shelves in ... numbers ever since. The small packets can be tossed ... out a liquid or powder. The convenience, though, has ... study from researchers at Nationwide Children,s Hospital found that ... reports of 17,230 children younger than 6 years of ...
(Date:11/6/2014)... Most cancer deaths occur because of metastasis, yet ... has been slow. , "It,s been particularly challenging ... Taran Gujral, research fellow in systems biology at ... aren,t detected until after they,ve already metastasized." , ... culprit that should help researchers better understand how ...
Breaking Biology News(10 mins):FDA's Janet Woodcock, EMA's Emer Cooke Headline PDA Quality Metrics Conference 2Study finds laundry detergent pods, serious poisoning risk for children 2Migration negation 2Migration negation 3
... researchers have discovered a novel molecular mechanism that can ... progression of some cancers. In the March 23 online ... scientists from the University of Montreal explain how they ... of inflammatory cytokines that normally activate the immune system, ...
... diagnosis is critical in treating Lyme disease. However, ... initially misdiagnosed because currently available serological tests have ... of infection. Misdiagnosed patients may go untreated and ... face longer and more invasive treatments, as well ...
... National Renewable Energy Laboratory (NREL) recently convened the ... with a mission to enable securitization of solar ... marketplace. SAPC,s primary efforts center on the ... documents relevant to residential and commercial deployment, and ...
Cached Biology News:University of Montreal researchers discover how drug prevents aging and cancer progression 2Penn Researchers attach Lyme disease antibodies to nanotubes, paving way for diagnostic device 2Penn Researchers attach Lyme disease antibodies to nanotubes, paving way for diagnostic device 3Penn Researchers attach Lyme disease antibodies to nanotubes, paving way for diagnostic device 4NREL assembles industry working group to advance solar securitization 2
Packaging: package with 500 l Patent/trademark/license (electronic): (r) Registered trademark of Molecular Probes...
... 100-120 V, is used for protein separation ... The system includes both the mini (18 ... chassis, harvesting apparatus, cooling finger, electrode chambers, ... ml syringe, colored protein sample, 2 vent ...
...
... NH2 is primarily used for the preparation ... proteins for tracing. NH2-Reactive B-Phycoerythrin, a component ... and can easily make a covalent bond ... proteins without any activation process. Filtration Tube ...
Biology Products: